Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis

Part of paid clinical trials in North Chicago, Illinois.

Sponsor
Abbott
Study ID
NCT00234897
Phase
PHASE4
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of the study is to assess the efficacy of adalimumab in subjects with rheumatoid arthritis focusing on subject-reported outcomes and early response to treatment

Key Dates

First listed
Oct 10, 2005
Start date
Aug 31, 2004
Status verified
Aug 2007

Study Design

Enrollment
1,938 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Primary Outcome Measure

Patient reported outcomes, clinical response indicators.

Locations (1)

FacilityCityStateZIPSite coordinators
Global Medical Information - AbbottNorth ChicagoIllinois60064-

Find similar trials in North Chicago, IL

Nationwide
Rheumatoid arthritis trialsRheumatology trialsAutoimmune disease trialsMusculoskeletal disorders trials
By condition
Rheumatoid arthritis
By specialty
RheumatologyAutoimmune diseaseMusculoskeletal disorders
By research site
Global Medical Information - Abbott· North Chicago, IL

Related Studies